
    
      A long-term, multicentre, double-blind, randomised parallel-group trial to determine whether
      reducing post-prandial glycaemia can reduce cardiovascular-related morbidity and mortality in
      patients with established coronary heart disease or acute coronary syndrome who have impaired
      glucose tolerance.
    
  